Controlling Seizures in Children: Diazepam or Midazolam? Systematic Review
Hong Kong Journal of Emergency Medicine · 2010-04-01 · Systematic review
Abstract
Introduction Diazepam is commonly used to treat acute childhood seizures, but difficulty gaining intravenous access and variability of absorption after rectal administration can limit its efficacy. Midazolam is a water soluble benzodiazepine that has a rapid onset of action after intranasal or buccal administration and provides an alternative to diazepam in the control of acute childhood seizures. Methods A literature search was performed to identify papers comparing the efficacy and tolerability of midazolam and diazepam in the management of childhood seizures. Results Intranasal or buccal midazolam are at least as effective as rectal or intravenous diazepam in controlling acute childhood seizures. In all robust studies reporting a significant difference, time to gain seizure control was shorter in patients treated with midazolam than those treated with diazepam, predominantly due to shorter drug administration time. The incidence of seizure recurrence was lower in patients treated with midazolam than diazepam. Respiratory depression was uncommon in both groups. Conclusion Intranasal or buccal midazolam provides a safe, effective and acceptable alternative to intravenous or rectal diazepam in the management of acute childhood seizures.
Abstract © the authors or publisher, via OpenAlex. Reuse and removal
Tags
Children · Diazepam · Intranasal administration · Midazolam · Sedatives & anxiolytics
Related articles
- Efficacy and safety of intranasal and buccal midazolam versus intravenous, intramuscular, and rectal benzodiazepines for the termination of acute seizures in children: a systematic review and meta-analysis. (Seizure, 2026)
- Comparison of buccal midazolam and rectal diazepam for seizures in children (Journal of Paramedic Practice, 2023)
- Termination of seizures in the paediatric age group, best benzodiazepine and route of administration: A network meta-analysis. (Eur J Neurosci, 2022)
- Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. (Cochrane Database Syst Rev, 2018)
- Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available: Systematic review and meta-analysis. (Epilepsy Res, 2016)
- A Common Reference-Based Indirect Comparison Meta-Analysis of Buccal versus Intranasal Midazolam for Early Status Epilepticus. (CNS Drugs, 2015)